Sol-Gel Technologies (SLGL) Assets Growth (5y) (2021 - 2026)

Sol-Gel Technologies (SLGL) Assets Growth (5y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.78%
Dec 31, 2025 -12.75%
Sep 30, 2025 -12.21%
Jun 30, 2025 -12.04%
Mar 31, 2025 -18.83%
Dec 31, 2024 -10.18%
Sep 30, 2024 -8.74%
Jun 30, 2024 -7.90%
Mar 31, 2024 -10.11%
Dec 31, 2023 -8.26%
Sep 30, 2023 -9.17%
Jun 30, 2023 -8.59%
Mar 31, 2023 -11.42%
Dec 31, 2022 24.94%
Dec 31, 2021 44.49%